Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-02-23

Clinical Trial Update: Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications [Phase 3]

View source ↗

Summary

A Phase 3 pilot trial evaluating the effect of teduglutide on temporary ileostomy function and complications has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Ileostomy - Stoma | Phase 3 | Status: WITHDRAWN